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INTRODUCTION
Neutrophils are bone marrow (BM)-derived myeloid cells that play pivotal roles in anti-cancer immunity. 1 These cells are produced at a rate of 10 11 per day 2,3 and they comprise 50 -70% of blood leukocytes when released into circulation. Due to this rapid turn-over in the body, neutrophils have traditionally been viewed as a homogeneous population. However, recent work has shown that they exhibit a longer life cycle than previously thought 4 ; reviving interest in the possibility of distinct neutrophil populations. 3, 5 Spurred on by such findings, several groups have identified and characterized neutrophil subpopulations. For example, use of density gradient separation has uncovered distinct, lowdensity (LDN) and high-density neutrophil (HDN) populations, each with opposing actions in immune regulation and cancer progression. 6 Marini and coauthors employed flow cytometry to show that CD10 + and CD10neutrophils represent cell populations with opposing effects on T cell proliferation. 7 Pillay and colleagues identified 3 neutrophil subpopulations, based on their differential expression of CD16 and CD62L, which exhibit specific maturation and activation statuses. 8 CD45RA-positive expression in certain neutrophils was also found to indicate activation statuses. 9 Singhal and collaborators isolated a CD14 + neutrophil subpopulation with anti-tumor functions, including enhancement effector T cell production of IFN-g and Granzyme B. 10 Evrard and colleagues have demonstrated a CD15 + CD49 + CD101neutrophil precursor (preNeu). 11 Our group has also identified a CD117 + CD66b + CD38 + neutrophil progenitor (NeP), which was found in the blood of tumor-bearing animals. 12 Additional work in this area is summarized in two excellent review articles. 13, 14 Nevertheless, a lack of widely-accepted subpopulation markers has impeded our understanding of neutrophil heterogeneity. Indeed, the neutrophil subpopulations thus far described likely represent overlapping populations. Flow cytometry analysis suggests that CD10 + and CD10neutrophil subpopulations are fractionated into both LDN and HDN layers. 7 Furthermore, the CD10 + expression demonstrated by Marini et al 7 is shared by the CD16 bright subpopulation reported by Pillay et al. 8 CD14 + neutrophils express CD10 -, 10 suggesting that this subpopulation overlaps with the CD10neutrophil population. 7 The CD14 + neutrophil subpopulation also expresses CD49d + , indicating that it could also overlaps with the CD49d + preNeu demonstrated by Evrard et al, 11 as well as a CD49d + CD62L lo neutrophil subpopulation ("aged neutrophil") reported by Zhang et al. 15 To determine the extent to which previously reported neutrophil subpopulations intersect, high-dimensional analysis of neutrophil heterogeneity on single-cell basis is imperative.
We and others have employed high-dimensional approaches such as single-cell cytometry by time of flight (CyTOF) and single-cell RNA sequencing (scRNA-seq) to address neutrophil heterogeneity. These endeavors demonstrate that neutrophil-lineage cells comprise a heterogeneous pool in mouse and human BM. 11, 12 Additionally, recent scRNA-seq analyses reveal 6 neutrophil clusters with distinct transcriptional signatures in human lung tumors but the surface markers needed to classify these populations were not identified. 16 Interestingly, work in this field has also suggested differential involvement of neutrophil subpopulations in cancer. 17, 18 Thus, the development of neutrophil consensus markers is required for improving our understanding of neutrophil biology and its relationship to disease progression.
Here, we utilize a CyTOF panel of the most-commonly used surface markers of neutrophil maturation, activation, and function to comprehensively investigate neutrophil heterogeneity in whole blood (WB) from treatment-naïve melanoma patients. High-dimensional analysis of this dataset revealed 7 neutrophil subpopulations associated with disease stage and which are reproducible during manual gating in flow cytometry. Finally, we found that these 7 neutrophil subpopulations harbor distinctive functions, demonstrated by their differential capacities for phagocytosis and reactive oxygen species (ROS) production.
METHODS

Melanoma patient blood collection
Blood samples from melanoma patients who were treatment-naïve post-surgical resection were collected in EDTA-coated tubes by the Biospecimen Repository Core Facility (BRCF) at the University of Kansas Cancer Center and delivered to La Jolla Institute for Immunology (LJI) via overnight shipping. Concurrently, blood from healthy donors were collected in EDTA-coated tubes at LJI. To ensure uniform treatment between control and experimental materials, all healthy donor blood samples were stored at 4°C overnight and then processed at the next morning.
Healthy donor blood collection
EDTA-coated blood from healthy volunteers was obtained after written informed consent under the guidelines of the Institutional Review Board of LJI and in accordance with the United States
Department of Health and Human Services' Federal Policy for the Protection of Human
Research Subjects (VD-057-0217).
Cell suspension from human whole blood
Whole blood (WB) was subject to red blood cell lysis (RBC lysis buffer, eBiosciences) twice at room temperature (RT) for 10 min. Cells were then washed with staining buffer (D-PBS + 1 % human serum + 0.1 % sodium azide + 2 mM EDTA) and filtered through a 70 µm strainer. Cell suspensions were prepared by sieving and gentle pipetting to reach final concentration of 3 x 10 6 cells per 100 uL buffer.
Mass cytometry antibodies
Metal-conjugated antibodies were purchased directly from Fluidigm for available targets. For all other targets, purified antibodies were purchased as described before. 19 Antibody conjugations were prepared using the Maxpar Antibody Labeling Kit (Fluidigm) according to the manufacturer's recommendations. Afterwards, Maxpar-conjugated antibodies were stored in PBS-based antibody stabilization solution (Candor Biosciences) supplemented with 0.05% sodium azide at 4°C. All antibodies were titrated before use.
Mass cytometry (CyTOF)
CyTOF was performed following previously described protocols. 20 For viability staining, cells were washed in PBS and stained with Cisplatin (Fluidigm) at a final concentration of 5 µM. Prior to surface staining, RBC-lysed WB cells were resuspended in staining buffer for 15 minutes at RT to block Fc receptors. The surface antibody cocktail listed in Table 2 
Flow cytometry and cell sorting
All FACS staining was performed in staining buffer at 4°C. Cells were filtered through sterile, 70 µm cell strainers to obtain single-cell suspensions (30, 
Phagocytosis
Phagocytic capacities of neutrophils were assessed with a Phagocytosis Assay Kit (Red Zymosan) (Abcam) following the manufacturer's protocol. RBC-lysed WB cells were diluted to a concentration of 3 x 10 6 cells in 1 mL buffer and incubated with 5 µL of Zymosan slurry per sample at 37°C and 5 % CO 2 for 2.5 hours. Afterwards, the samples were centrifuged for 5 minutes at 400 x g and then stained with 100uL antibody cocktail for flow cytometry-based detection of phagocytosis of Red Zymosan particles by neutrophils.
Cellular ROS detection
ROS production by neutrophils was detected with a Cellular ROS Detection Assay Kit (Abcam)
following manufacturer's manual. The RBC-lysed WB cells were diluted to the concentration of 3 x 10 5 cells in 100 mL buffer. Pre-treatment with ROS inhibitor (N-acetyl-L-cysteine) was carried out for the negative control group at 37°C, 5 % CO 2 for 30 minutes. ROS detection antibody then added into the antibody cocktail for flow cytometry-based detection of neutrophil ROS production. ROS inducer (pyocyanin) was added to all groups and incubated for 30 minutes prior to acquisition on the cytometer.
Quantification and statistical analyses
Data for all experiments were analyzed with Prism software (GraphPad). For Figure 2 , linear regression and Pearson correlation coefficients were used to determine the correlation between neutrophil cluster frequencies with melanoma stages. P values were calculated based on twotailed comparisons with 95 % confidence intervals and shown in APA style. For all bar graphs, error bars indicate mean ± SD.
RESULTS
CyTOF reveals 7 neutrophil clusters in blood from melanoma patients
In order to identify novel blood neutrophil populations, we utilized cytometry by time of flight (CyTOF) to analyze red blood cell (RBC)-lysed fresh blood samples from a cohort of 21 melanoma patients (Table 1) . At the time of sample collection, these patients were recently diagnosed, had not received any treatment for their condition post-surgery (treatment-naïve), and ranged from 24 to 82 years of age, with a median age of 69 years ( Table 1) . After processing, samples were subjected to a CyTOF antibody panel that simultaneously measured the expression of 40 neutrophil surface markers ( Table 2 ). Leukocyte lineage markers ( Table 2) were used to perform visualization of t-distributed stochastic neighbor embedding (viSNE)automated analysis to study live CD45 + single cells in blood (Supplemental Figure 1A ).
Neutrophils (CD66b + cell-enriched cluster) were distinguishable from all other leukocytes using this strategy (Supplemental Figure 1B) .
We focused on the CD66b + cell-enriched cluster to analyze the heterogeneity of neutrophils across all patient samples. Our results demonstrate that these samples contained a CD117 + CD66b + , hNeP population ( Figure 1A ), which we formerly identified. 12 In addition, FlowSOM analyses 22 revealed another 6 neutrophil clusters (termed N 1 through N 6 , Figure 1B ), each with distinct surface marker profiles ( Figure 1C ). As maturity markers are commonly used to distinguish circulating neutrophil subpopulations in cancer 11, 23 , we next quantified expression levels of these markers in the N 1 -N 6 clusters. We found that cluster N 2 expresses high levels of CD101, CD10, and CD16 compared with the other clusters, indicating that this cluster represents terminally differentiated, mature neutrophils ( Figure 1C and D). 7 Furthermore, CD10 lo clusters (N 1 , N 3 -N 6 ) express reduced levels of CD101, highlighting their immaturity when compared to the N 2 cluster ( Figure 1D ). The N 1 , N 3 , and N 6 clusters express progenitor markers (CD34 and CD117) at a lower level than hNeP, suggesting a precursor phenotype for these 3 clusters ( Figure 1D ; supplemental Figure 2A ). In the N 5 cluster, expression of CD34 and CD117 was diminished, compared to the N 1 , N 3 , and N 6 clusters. In contrast, CD10 and CD16 levels were higher in the N 5 cluster, compared to N 3 and N 6 , intimating that this cluster denotes nonproliferative immature neutrophils ( Figure 1D ). Moreover, the N 3 and N 6 neutrophil clusters both express CD101 -CD49d + , which suggests these clusters belong to the neutrophil precursor (preNeu) population. 11 We further characterized these neutrophil clusters by comparing functional markers previously used to evaluate neutrophil populations ( Figure 1E ). In agreement with initial findings ( Figure 1C ), N 2 showed the highest CXCR2 levels, confirming its maturation status.
Interestingly, N 3 and N 6 , which are both from the CD101 -CD49d + preNeu pool, expressed different levels of CD45RA and CD14. CD45RA was expressed only by N 3 whereas CD14 was exclusively expressed by N 6 . Additionally, N 3 exhibited higher CXCR4 levels, compared with cluster N 6 , which categorizes this group as likely the previously reported, "aged" or senescent (CXCR4 + CD49d + CD62L lo ) neutrophil population (supplemental Figure 2B ). 15 Finally, N 1 and N 6 expressed low amounts of CD16, compared to N 2 ( Figure 1D ), and stained positive for CD62L ( Figure 1E ), suggesting these cells are the CD16 dim CD62L bright band cells that have been described prior. 8 Overall, our approach is able to call both novel and established neutrophil populations from melanoma patients.
Neutrophil heterogeneity correlates with melanoma stage
Based on the aforementioned results, we sought to determine the frequency of each neutrophil cluster in our patient samples. Regression analysis of each cluster's (hNeP and N 1 -N 6 ) percentage within total neutrophils determined that decreased N 2 frequencies correlated with melanoma stage (Pearson r = 0.5473, p = 0.023) ( Figure 2A ). We did not observe significant correlations between specific clusters or patient demographics such as age and sex, nor tumor characteristics such as anatomice site or ulceration status (Table 1) . However, the overall frequency of precursors/immature neutrophils (hNeP, N 1 , N 3-5 ) increased up to 4-fold with disease prognosis ( Figure 2B , supplemental Figure 3A ). Thus, we hypothesized that different patterns of neutrophil heterogeneity demonstrated by cluster frequencies are predictive of disease stage. To test this hypothesis, we categorized patients into 4 different groups (A-D) based on these patterns, as analyzed by viSNE ( Figure 2C From this analysis, we determined that patients in Group C have the highest hNeP, N 1 and N 3 frequencies. Patients included in Group D have the highest N 4 and N 5 frequencies ( Figure 2D ).
The percentage of the mature, N 2 cluster progressively decreases from patient Group A to D.
We next investigated the melanoma stage of the patients in these 4 groups ( Figure 2E ).
Interestingly, patients in Group A were all diagnosed with early stage cancer whereas groups C and D contained the highest percentages of stage III and stage IV patients. These results suggest that specific patterns of neutrophil heterogeneity are associated with melanoma progression and may assist in patient grouping and diagnosis.
Flow cytometry recaptures the 7 neutrophil subpopulations in melanoma patients' blood
We then asked if the markers highlighted in our in silico analysis could be used to devise a manual gating strategy for replicating the 7 neutrophil clusters identified by CyTOF ( Figure 3A; supplemental Figure 4 ). Thus, we first used manual gating to isolate total neutrophils from the CyTOF data. These cells overlapped with 90% of our automated CD66b + cell-enriched cluster by backgating (Supplemental Figure 4) . By first applying a manual gate for CD66 + neutrophils, we were able to identify the 7 subpopulations by their expression patterns of CD117, CD79b, CD45RA, CD16, CD49d, CD101, and CD10. To verify whether manually gated populations mirror automated clusters, we validated this gating strategy by: 1) back-gating the manuallygated subpopulations to the automated viSNE map and 2) back-gating automated clusters to the manual gates (supplemental Figure 5A, B) . Both methods confirmed that our manual gating strategy is able to successfully isolate the CyTOF-identified hNeP and N 1 -N 6 clusters.
Next, we further validated this manual gating strategy (Supplemental Figure 4 ; Figure   3A ) via flow cytometry (Supplemental Figure 5C ; Figure 3B , C). To validate the utility of these findings as they relate to cancer, we investigated neutrophil heterogeneity in 5 healthy donors (age 23-46, 2 female, 3 male) and compared them to 5 additional treatment-naïve melanoma patients (aged 59-79 years, 2 female and 3 male). We observed that the N 2 population comprises >95% of total neutrophils in healthy donors, whereas the other populations (hNeP, N 1 , N 3 , N 4 , N 5 , N 6 ) were rarely detected ( Figure 3C, D) . Moreover, compared to healthy donors, these subpopulations (hNeP, N 1 , N 3 , N 4 , N 5 , N 6 ) appeared more frequently in treatment-naïve melanoma patients, which occupied >10% total neutrophils, as determined by flow cytometry.
The frequencies of N 2 , however, were reduced to <90% of total neutrophils in melanoma-patient blood. Finally, we randomly selected blood from two of these additional healthy controls and performed CyTOF with the same high-dimensional analysis settings that we used to generate the results in Figure 1 (Supplemental Figure 6 ). Confirming our results above, neutrophils from healthy donors contained over 95% of the mature, N 2 subpopulation ( Figure 3E ). This result is consistent with prior findings showing that both immature neutrophils and neutrophil precursors are mobilized to the circulation in cancer. 24, 25 The 7 neutrophil subpopulations perform diverse immune functions Afterwards, we sought to determine whether the 7 neutrophil subpopulations we identified express different immunological phenotypes. Phagocytosis and generation of reactive oxygen species (ROS) are two major functions of neutrophils in the immune system. 26 Therefore, we evaluated the 7 neutrophil subpopulations' phagocytic and ROS-producing capacities. Figure 4B, C) . Indeed, the phagocytic abilities of hNeP and N 1 were comparable to, or higher than, that of monocytes collected from the same donors (supplemental Figure 7A, B) . Moreover, the phagocytic capabilities of the other subpopulations were reduced by 3-to >20-fold ( Figure 4B, C) . Despite the fact that N 2 and N 5 harbor lower phagocytic capacity compared to hNeP and N 1 , they are the most prevalent neutrophil subpopulations in melanoma patients' blood ( Figure 1 and 2) . Therefore, the absolute numbers of Zym+ N 2 and N 5 cells still comprise the largest portion (about 50%) of all phagocytic (Zym+) neutrophils and about 25% of total phagocytic CD45 + leukocytes (supplemental Figure   7C , D).
Finally, we sought to determine the ability of neutrophil subpopulations to produce ROS. Figure   4D ). However, these cells significantly differ from one another in terms of their ability to produce ROS. For instance, the N 2 and N 5 displayed the highest capacity to produce ROS as determined by the percentage of ROS+ cells in the inducer alone (+ sti) group ( Figure 4E ). Meanwhile, populations N 4 and N 6 showed the lowest ROS-producing capacity of all the subpopulations, with levels comparable to those produced by monocytes ( Figure 4E ; supplemental Figure 7E ).
To eliminate confounding by non-inducer-specific ROS production by each population during incubation, we compared the fold-change (FC) of ROS gMFI in the inducer alone (+ sti) group to the no stimulation (-sti) group. The FC result agreed with our observation that the N 2 has the highest ROS-producing capacity ( Figure 4F ). Additionally, we found that all these subpopulations respond to the ROSi at different levels. In brief, pre-treatment with ROSi blocked ROS production in N 2 by 85% whereas the blocking efficacy reached only around 25% in N 4 (Supplemental Figure 7F ). Together, our data indicate that the 7 neutrophil subpopulations harbor different immune capabilities.
DISCUSSION
Neutrophil heterogeneity has become an active research area, particularly with regards to cancer progression. 17 Comprehensive examination by flow cytometry has revealed that neutrophils express a complex surface antigen profile. 27 However, due to the limitations imposed by flow cytometry, researchers have had to arbitrarily select only a few surface markers to examine at a particular time. For example, studies in lung cancer research use one set of markers to identify their neutrophils of interest whereas studies in infectious diseases use another set of markers; this is also the case for work on the role of neutrophils in hematopoiesis and angiogenesis. 14, 18 Consequently, neutrophil subpopulations reported by different groups mostly share individual features such as CD66b and/or CD15 but vary in regards to the assessement of other surface antigens. Thus, a lack of consensus markers for neutrophils and their functional subpopulations remains a challenge in the identification of particular diseaserelevant subpopulations.
High-dimensional analysis of neutrophils at the single-cell level is needed to resolve issues associated with identifying neutrophil consensus markers. To meet this demand, we and others have utilized CyTOF to investigate novel neutrophil progenitors/precursors in BM. 11, 12 Zilionis and colleagues have reported a comprehensive analysis of myeloid cell heterogeneity via single-cell transcriptomics in non-small-cell lung cancer (NSCLC). 16 This study found 6 blood neutrophil populations with unique gene signatures in these patients, a myeloid precursor-like population was also found but remained uncharacterized. However, the genes that encode surface markers were not discussed in this study, making it a challenge to compare these neutrophil and myeloid precursors to established neutrophil subpopulations.
Here, we have designed a CyTOF panel that reflects our integration of markers reported on in the published data and which evaluates the most commonly used surface antigens. Our aim was to establish a paradigm for characterizing neutrophil heterogeneity, focusing on patients with melanoma. We have identified 7 neutrophil clusters in treatment-naïve melanoma blood by CyTOF. Each patient exhibited a distinct neutrophil heterogeneity pattern, based on each cluster's frequency as a proportion of total neutrophils. We have identified groups of patients based on similarities between these neutrophil heterogeneity patterns. The patient groups displayed different melanoma stage categories, suggesting a link of neutrophil heterogeneity to stage of the disease, yet prospective validation is needed. We have also shown that these automated neutrophil clusters can be reproduced by manual gating in conventional flow cytometry. Furthermore, we demonstrate that these neutrophil subpopulations exhibit significantly different capacities for phagocytosis and ROS production. Thus, we anticipate that these subpopulations may play different roles in cancer initiation and/or progression.
However, it must be emphasized that the CyTOF panel used in this study is selective for human blood neutrophil-and cancer-markers and therefore likely will not capture neutrophil heterogeneity across species, organs, and/or different diseases. We also cannot rule out higher dimensions of heterogeneity within our reported subpopulations and such investigations should be the focus of future work. Furthermore, we are unable to rule out the possibility of phenotype switching between these 7 subpopulations and thus consider this notion an interesting direction for future investigation. 6, 28 A final caveat to our gating strategy is that some rare neutrophil subpopulations, such as those expressing TCR-like receptor, 29 could be lost.
The results presented here suggest that some previously identified neutrophil subpopulations overlap with one another 6, 11, 15 and/or represent a mixed pool. 8, 30 This study has provided a flow cytometry gating strategy based on CyTOF analysis to isolate 7 distinctive neutrophil subpopulations. Our results show that these subpopulations display differing capacities to phagocytize debris and produce ROS. Interestingly, a decrease in the ability of T cells to bind pMHC and to respond to specific peptides is induced by myeloid cell-based production of ROS. 31 Conversely, myeloid production of ROS has been shown to be indispensable for antigen-specific responsiveness in both CD4+ and CD8+ T cells. 32 This controversial role of ROS in regulating T cell responses could be partially explained by the dual role of ROS; at low to moderate concentrations ROS is beneficial for cell survival, whereas high levels of ROS can induce cell death. 33 Therefore, the 7 differing abilities of these neutrophil subpopulations to produce ROS suggests that they carry out different roles in regulating T cell responses in cancer. Table 1 . Patient demographics and tumor characteristics. Table 1 were used for this analysis. The numbers of subjects in each melanoma stage are indicated on the graph.
TABLES
(C) Bar graph shows the mean percentage of each cluster in patient Groups A-D. All patients were used for this analysis, regardless of whether or not they received a melanoma stage diagnosis ( Table 1 ). The numbers of subjects in each group are indicated below each column.
(D) Violin plots shows the neutrophil cluster frequency in patient pools A-D. Quartiles and median value of each patient pool are indicated as dotted lines. All patients were used for this analysis, regardless of whether or not they received a melanoma stage diagnosis ( Table 1) 
. (E)
Bar graph shows the percentage of patients at different melanoma stage (Table 1) 
in patient
Groups A-D. N/A indicates missing diagnosis information of patients. All the patients were used for this analysis, regardless of whether or not they received a melanoma stage diagnosis ( Table   1 ). The numbers of patients in each pool are indicated below each column. Table 1 were stained with the CyTOF panel in Table 2 . (A) Live CD45 + cells were gated to determine the singlets for subsequent analysis. (B) Singlets were subjected to automated analysis. Left, mean intensities of each indicated marker were shown on viSNE map as spectrum colored dots (low in blue, high in red). Right, the blood cell types of each automated cluster were identified based on the hallmark marker expression shown at left panel and was displayed on viSNE map as dot overlays. Neutrophils (Neuts) were identified as the CD66b + cluster (blue cluster). Singlets gated in supplemental Figure 1A were subjected to manual gating strategy. CD66b + blood neutrophils were manually selected by sequential gating, backgated to the viSNE map (green), and then overlapped with automated CD66b + cluster (blue). Scales are shown in arcsinh transformation with cofactor equal to 5. 
